Hospital Pharmacy Europe

APRIL 24, 2025

The Medicines Optimisation Innovation Centre (MOIC) in Northern Ireland has become a pivotal force in advancing healthcare, particularly in the essential field of medicines optimisation. In this case study, marking a decade since its inception, Katherine Redpath examines MOICs achievements, ongoing projects and future aspirations. The suboptimal use of medicines presents a significant global challenge 1 , resulting in adverse health outcomes, inefficiencies and considerable waste.

Nursing Homes 59

Nursing Homes Hospitals Community Pharmacies Communication 59

Drug Topics

APRIL 22, 2025

Researchers conducted an observational cost analysis of dermatology drug savings between GoodRx and Mark Cuban Cost Plus Drug Company.

684

684

STAT

APRIL 25, 2025

Health and Human Services Secretary Robert F. Kennedy Jr. has railed against what he sees as a “revolving door” between workers at drug companies and the Food and Drug Administration. But his department’s actions now seem to be causing that door to spin ever faster.  Scores of FDA employees are searching for an exit from an agency in turmoil, particularly staff members tasked with reviewing drug applications, according to interviews with former employees and industry re

FDA 139

FDA 139

PharmaVoice

APRIL 22, 2025

The discoveries also hold potential benefits for patients with other conditions, such as chronic fatigue syndrome.

342

342

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

European Pharmaceutical Review

APRIL 21, 2025

For the first time in over ten years, the US Food and Drug Administration (FDA) has approved a new targeted treatment for chronic spontaneous urticaria. Sanofi and Regeneron Pharmaceuticals collaborated to develop Dupixent (dupilumab). Under the FDA’s new authorisation, the therapy is indicated for individuals aged 12 years and over with the chronic inflammatory skin disease, who still experience symptoms despite taking histamine-1 (H1) antihistamine medication.

FDA 105

FDA 105

Drug Topics

APRIL 22, 2025

CVS releases a statement shortly after HB1150 was signed in Arkansas, prohibiting pharmacy benefit managers from owning pharmacies.

530

530

PharmaVoice

APRIL 25, 2025

A look at the government’s far-reaching rollback in research grants so far.

245

245

Pharmafile

APRIL 25, 2025

Vect-Horus has announced the appointment of Philippe Masset to the companys board of directors. This contributes to a series of senior leadership appointments which are strategic for Vect-Horus growth. Masset is a senior banking executive with a wealth of experience in investment banking, environmental, social and governance (ESG) topics, sustainable finance, and AI.

76

76

Drug Topics

APRIL 22, 2025

Further, the authors of the Standards of Care in Diabetes 2025 highlighted the benefits of continuous glucose monitoring systems and recommend initiating these as soon as possible.

498

498

STAT

APRIL 24, 2025

Some key public health figures are taking an extraordinary step to try to shore up U.S. vaccination policy, feared to be under threat from Health and Human Services Secretary Robert F. Kennedy Jr., a longtime vaccine critic. The “Vaccine Integrity Project,” which was publicly launched Thursday by the University of Minnesota’s Center for Infectious Disease Research and Policy, will be aimed at assessing the best ways for vaccine proponents to safeguard vaccination policy and

Vaccines 135

Vaccines 135

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PharmaVoice

APRIL 21, 2025

Five GLP-1 products will collectively bring in $470 billion by 2030, and the market leaders are working to hold back competition.

221

221

Pharma Marketing Network

APRIL 25, 2025

Introduction In todays complex healthcare environment, what does it truly mean to practice Integrated Marketing Communications in pharma? For brands like Keytruda , Humira , and Ozempic , success isnt just about having a powerful product. Its about delivering consistent, engaging messages across a fragmented media landscape. Much like a symphony that requires every instrument to be in sync, pharma marketers must harmonize every touchpoint to resonate with both healthcare professionals and patien

Communication 59

Communication Pharmaceutical Companies Pharmaceutical Companies HIPAA 59

Drug Topics

APRIL 23, 2025

Investigators specifically analyze information on influenza and pneumococcal vaccinations.

Vaccines 476

Vaccines 476

STAT

APRIL 24, 2025

The federal health department is not creating a new registry of Americans with autism, a Department of Health and Human Services official said in a written statement Thursday. Instead, the official said, HHS will launch a $50 million research effort to understand the causes of autism spectrum disorder and improve treatments. The announcement arrives two days after National Institutes of Health Director Jay Bhattacharya announced the intent to create such a registry at an all staff meeting, kicki

Insurance 145

Insurance 145

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PharmaVoice

APRIL 21, 2025

SpringWorks Therapeutics and the Children’s Tumor Foundation salvaged a shelved asset for neurofibromatosis and got it over the regulatory finish line.

182

182

Pharmafile

APRIL 25, 2025

Two clinical-stage oncology programmes from Astex Pharmaceuticals have been announced by Mosaic Therapeutics, allowing it to develop targeted oncology drug combinations. This elevates the research and platform company to a clinical-stage oncology business, bringing products closer to commercialisation and market access. Mosaic now has exclusive rights to develop its combination products in these trials.

64

64

Drug Topics

APRIL 25, 2025

The findings support the need for improved vaccination coverage to prevent the resurgence of previously eliminated infectious diseases in the United States.

Vaccines 463

Vaccines 463

STAT

APRIL 24, 2025

The debate over the future of Medicaid continues to rage among Republicans. A House budget proposal released in February would slash up to $880 billion in spending over the next decade from the public health insurance program that 80 million low-income Americans rely on — including children, seniors, and people with disabilities.

Insurance 119

Insurance 119

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

PharmaVoice

APRIL 24, 2025

A new AI-based company launched by the prolific venture capital firm Flagship Pioneering marks another platform approach in forward-thinking early science.

162

162

Pharma Marketing Network

APRIL 22, 2025

Introduction Pharma brands are rethinking their digital engagement strategies in 2025. With regulatory scrutiny evolving and audience expectations shifting, social media marketing plans have become a central focus for companies looking to maintain trust while expanding reach. Social platforms are no longer just optional toolsthey’re vital channels for HCP and patient engagement.

FDA 59

FDA 59

Drug Topics

APRIL 20, 2025

From 1990 to 2021, researchers explored the global burden of atopic dermatitis among older adults.

459

459

STAT

APRIL 24, 2025

NASHVILLE, Tenn. — Robert F. Kennedy Jr.’s appearance at a major addiction and drug policy conference was marked by repeated interruptions on Thursday, as protesters and jeers forced him to pause and wait for noise to subside at least five times during his 36-minute speech.  A packed and deeply divided audience at the Rx and Illicit Drug Summit, taking place at a conference center on the city’s outskirts, applauded the health secretary as he entered and exited the stage

120

120

The FDA Law Blog

APRIL 21, 2025

By John W.M. Claud & Michelle L. Butler Recent reductions in force (RIFs) and leadership changes at FDA are already affecting key agency functionsand as the administration plans a broader reorganization, the impact will likely grow. One area drawing increasing attention is how these changes will affect the drug development and review process. As reported by the Wall Street Journal last week , reviews of both innovative and follow-on drugs have been caught in a traffic jam, largely due to a

Documentation 64

Documentation FDA 64

Pharmafile

APRIL 25, 2025

Flemish biopharma company, Bioxodes, has announced promising results from the BIRCH phase 2a clinical trial of BIOX-101 to treat intracerebral haemorrhagic stroke (ICH). This brings the company closer to rolling out the first approved treatment for the devastating condition. The BIRCH trial, which took place with 16 patients with ICH, met both primary safety and […] The post Successful clinical outcomes for drug treating rare stroke condition appeared first on Pharmafile.

59

59

Drug Topics

APRIL 21, 2025

The authors emphasize the importance of multifaceted and team-based approaches to the management of diabetes.

447

447

STAT

APRIL 25, 2025

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy. A federal judge on Thursday ruled against a compounding trade group’s request for a preliminary injunction that would have prevented the Food and Drug Administration from taking action against its members for making copies of semaglutide.

Compounding 96

Compounding Compounding Pharmacies FDA 96

Pharma Marketing Network

APRIL 24, 2025

Introduction Artificial Intelligence (AI) is no longer just a futuristic concept in pharmaceutical marketingits the present and future. In 2025, AI-powered pharma marketing is transforming how companies engage healthcare professionals (HCPs), patients, and stakeholders. With evolving compliance requirements and rising demand for personalization, pharma marketers are adopting intelligent platforms to stay ahead.

HIPAA 59

HIPAA FDA Pharmaceutical Companies Pharmaceutical Companies 59

PhRMA

APRIL 25, 2025

Every April 26th, World Intellectual Property (IP) Day marks a time to celebrate the creativity and innovation that fuel our economy. In 2025, the spotlight is on music—a universal language that connects people, culture and moments. But what if you couldn’t hear it? What if the joy of music was locked away, not by choice, but by biology?

146

146

Drug Topics

APRIL 21, 2025

Investigators find that orforglipron lowered A1c by an average of 1.3% to 1.6% from a baseline of 8% across 3 different dosages.

Dosage 373

Dosage 373

STAT

APRIL 21, 2025

Democrats recently unveiled a campaign to recruit and elect 100 doctors to public office. Democrats hope that by recruiting physicians to public office, they will be able to combat misinformation and restore trust in medicine and science.  Amid a full-blown measles outbreak, the U.S. plan to withdraw from the World Health Organization, the confirmation of Robert F.

101

101

Pharmafile

APRIL 24, 2025

ViroCell Biologics has manufactured a GMP-grade lentiviral vector for a University College London (UCL) clinical trial aimed at tackling relapse in paediatric acute lymphoblastic leukaemia (ALL), a common childhood cancer. Led by professor Persis Amrolia, a pioneer in CAR T-cell therapy at UCL and Great Ormond Street Hospital (GOSH), the trial intends to improve outcomes […] The post ViroCell and UCL launch trial to treat childhood leukaemia relapse appeared first on Pharmafile.

Hospitals 59

Hospitals 59

European Pharmaceutical Review

APRIL 25, 2025

The largest clinical trial investigating a treatment for bronchiectasis has demonstrated a statistically significant reduction in the occurrence of pulmonary exacerbations.Findings from the Phase III ASPEN study of brensocatib could provide future promise for patients, as there are currently no approved treatments for the chronic inflammatory pulmonary disease.

FDA 52

FDA 52

Drug Topics

APRIL 23, 2025

Researchers explored whether or not hormonal contraceptive initiation is associated with increased risk of developing depression within 12 months of child delivery.

363

363